Abbvie Inc. vs Cardinal Health, Inc.
ABBV vs CAH — side-by-side comparison from reported financials. ABBV leads 4, CAH leads 8 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Cardinal Health, Inc.
CAH · Healthcare
$237.57-0.58%Solid
| Metric | ABBV | CAH |
|---|---|---|
| Price | $276.43 | $237.57 |
| Market cap | $488B | $55.0B |
| Revenue (TTM) | $64.4B | $254B |
| Revenue growth | +1.8% | +7.4% |
| Net margin | 9.8% | 0.7% |
| Free cash flow | $18.2B | $4.53B |
| Net cash (debt) | ($56.2B) | ($5.14B) |
| 1-year price return | +19.8% | +51.1% |
| P/E | 77.4 | 32.1 |
| P/E vs own history (cheap-side %) | 23% | 26% |
| Dividend yield | 2.45% | 0.89% |
| Return on equity | 96% | 37% |
| Altman Z-score | 2.33 | 5.09 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 57,000 | 63,900 |
Full résumé-style profiles: ABBV CV · CAH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.